Chargement en cours...
Secondary Analysis of the Efficacy and Safety Trial Data of the Tetravalent Dengue Vaccine in Children and Adolescents in Colombia
BACKGROUND: The efficacy of the recombinant, live, attenuated, tetravalent dengue vaccine (CYD-TDV) against virologically-confirmed dengue (VCD) has been documented in a phase 3 trial in Latin America (CYD15, NCT01374516). This is a descriptive secondary analysis of the efficacy and safety of CYD-TD...
Enregistré dans:
| Publié dans: | Pediatr Infect Dis J |
|---|---|
| Auteurs principaux: | , , , , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Williams & Wilkins
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7182239/ https://ncbi.nlm.nih.gov/pubmed/32040014 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/INF.0000000000002580 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|